| open_canada_keywords |
{"fr": ["Recommandations", "utilisation", "vaccins", "contre", "la COVID-19", "2021", "September", "Vaccins", "immunisation", "Comité", "consultatif", "national", "immunisation", "CCNI", "Déclarations", "publications", "Méthodologie", "Épidémiologie", "Résumé", "facteurs", "risque", "liés", "complications", "sévères", "attribuables", "risque", "accru", "exposition", "Vaccins", "Préparations", "utilisation", "approuvée", "Tableau", "Vaccins", "contre", "utilisation", "approuvée", "Efficacité", "potentielle", "efficacité", "réelle", "Immunogénicité", "Administration", "vaccins", "Calendrier", "immunisation", "vaccin", "COVID", "Dépistage", "sérologique", "Conditions", "entreposage", "Administration", "concomitante", "autres", "vaccins", "Innocuité", "manifestations", "cliniques", "inhabituelles", "MCI", "Populations", "spéciales", "Contre-indications", "précautions", "Ingrédients", "associés", "réactions", "allergiques", "autres", "produits", "Interactions", "médicamenteuses", "Produits", "sanguins", "immunoglobulines", "humaines", "moment", "immunisation", "Recommandations", "Résumé", "considérations", "vaccins", "utilisation", "autorisée", "disponible", "Considérations", "matière", "vaccination", "selon", "types", "vaccins", "disponsibles", "approuvée", "Priorités", "matière", "recherche", "Questions", "liées", "surveillance", "Force", "recommandations", "Comirnaty", "Pfizer-BioNTech", "Efficacité", "première", "apparition", "maladie", "symptomatique", "après", "dose", "avant", "la deuxième", "dose", "participants", "16 ans", "plus", "symptomatique", "adolescents", "12 à 15 ans", "Spikevax", "Moderna", "Vaxzevria", "AstraZeneca", "15 jours", "dosage", "ensemble", "efficacité", "de base", "DS/DS", "séronégatif", "apparition", "hospitalisation", "intervalle", "ensemble", "efficacité", "potentielle", "infection", "asymptomatique", "Janssen", "confirmée", "modérée", "sévère", "critique", "se manifestant", "14 jours", "28 jours", "après la vaccination", "ensemble", "conforme", "protocole", "Séquençage", "génétique", "variant", "préoccupant", "septembre", "décembre", "2020", "pays", "comptant plus", "de 100 cas", "PCR", "centrale", "sites", "locaux", "confirmés", "manière", "centralisée", "centralisée", "sérologique", "ensemble", "protocole", "évènements", "indésirables", "locaux", "sollicités", "administration", "vaccins", "essais cliniques"], "en": ["Vaccines", "immunization", "National", "Advisory", "Committee", "Immunization", "NACI", "Statements", "publications", "Recommendations", "use", "COVID-19", "vaccines", "Methods", "Epidemiology", "Summary", "risk", "factors", "severe", "outcomes", "COVID", "increased", "exposure", "Preparations", "authorized", "Canada", "efficacy", "effectiveness", "Immunogenicity", "administration", "schedule", "serological", "testing", "Storage", "requirements", "Concomitant", "administration", "other", "safety", "adverse", "events", "following", "AEFI", "Special", "populations", "Contraindications", "precautions", "Ingredients", "associated", "allergic", "reactions", "products", "Drug", "interactions", "Blood", "products", "human", "immunoglobulin", "timing", "immunization", "Recommendations", "Vaccination", "considerations", "types", "Research", "priorities", "Surveillance", "issues", "Strength", "NACI", "Clinical", "trial", "evidence", "Pfizer-BioNTech", "Comirnaty", "against", "first occurrence", "symptomatic", "disease", "after dose 1", "before dose 2", "participants", "16 years", "age and older", "adolescents", "12 to 15 years", "Moderna", "Spikevax", "AstraZeneca", "Vaxzevria", "Estimates", "vaccine", "efficacy", "against", "first", "occurrence", "confirmed", "15 days", "dosing", "interval", "SD/SD", "seronegative", "baseline", "set", "hospitalization", "asymptomatic", "infection", "Janssen", "14 days", "28 daysm post-vaccination", "per-protocolm", "Genetic", "sequencing", "results", "VOC", "September-December", "2020", "symptomatic", "by country", "for countries", "greater", "100 moderate", "to severe", "critical cases", "centrally", "in-country", "PCR-confirmed", "cases", "moderate"]} |